Skip to content

A Study on the Application of Mindfulness-Based Cognitive Therapy (MBCT) in the Management of Patients with Severe Lower Limb Lymphedema After Comprehensive Treatment for Cervical Cancer

A Study on the Application of Mindfulness-Based Cognitive Therapy (MBCT) in the Management of Patients with Severe Lower Limb Lymphedema After Comprehensive Treatment for Cervical Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118945
Enrollment
Unknown
Registered
2026-02-13
Start date
2026-02-24
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with severe lower limb lymphedema after comprehensive treatment for cervical cancer

Interventions

Control group:21-day Complex decongestion therapy
Intervention group:The intervention group implemented mindfulness-based cognitive therapy on the basis of the control group

Sponsors

Hunan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.The patient has been diagnosed with cervical cancer through pathological examination; 2. The patient has undergone comprehensive treatment for cervical cancer; 3. The patient has been diagnosed with secondary severe lymphedema of the lower extremities through imaging examination; 4.The patient's disease has not recurred; 5.The patient has no history of cognitive impairment or mental illness; 6.The patient is able to understand the content of the questionnaire and complete the survey independently in written or oral form; 7.The patient voluntarily participates in this study and signs a written informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients with contraindications to CDT treatment; 2. Patients who refuse treatment; 3. Patients with comorbidities such as severe heart failure, renal failure, or other malignant lesions; 4. Patients with cognitive and communication impairments who cannot cooperate with treatment or follow-up; 5. Patients with psychiatric symptoms such as delirium; 6.Patients with a history of anxiety or depression; 7.Patients with speech communication disorders, hearing impairments, or cognitive dysfunction who cannot understand the questionnaire content and cannot complete the questionnaire independently as required.

Design outcomes

Primary

MeasureTime frame
Level of mindfulness;Psychological resilience level;Physical and psychological functions;Limb circumference;

Countries

China

Contacts

Public ContactSha Ye

Hunan Cancer Hospital

317816130@qq.com+86 136 3747 1664

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026